Guardion Health Sciences Valuation
| GHSIDelisted Stock | USD 3.29 0.04 1.23% |
At this time, the firm appears to be overvalued. Guardion Health Sciences retains a regular Real Value of $3.13 per share. The prevalent price of the firm is $3.29. Our model calculates the value of Guardion Health Sciences from evaluating the firm fundamentals such as return on equity of -0.5, and Return On Asset of -0.16 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Guardion Health's price fluctuation is dangerous at this time. Calculation of the real value of Guardion Health Sciences is based on 3 months time horizon. Increasing Guardion Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardion Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardion Pink Sheet. However, Guardion Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.29 | Real 3.13 | Hype 3.29 | Naive 4.13 |
The intrinsic value of Guardion Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Guardion Health's stock price.
Estimating the potential upside or downside of Guardion Health Sciences helps investors to forecast how Guardion pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardion Health more accurately as focusing exclusively on Guardion Health's fundamentals will not take into account other important factors: Guardion Health Total Value Analysis
Guardion Health Sciences is currently projected to have valuation of (987.33 K) with market capitalization of 4.39 M, debt of 3.77 M, and cash on hands of 14.23 M. The negative valuation of Guardion Health may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Guardion Health fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(987.33 K) | 4.39 M | 3.77 M | 14.23 M |
Guardion Health Investor Information
About 21.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guardion Health Sciences recorded a loss per share of 4.11. The entity last dividend was issued on the 24th of September 2024. The firm had 1:50 split on the 9th of January 2023. Based on the key indicators obtained from Guardion Health's historical financial statements, Guardion Health Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Guardion Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guardion Health has an asset utilization ratio of 102.77 percent. This signifies that the Company is making $1.03 for each dollar of assets. An increasing asset utilization means that Guardion Health Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Guardion Health Ownership Allocation
Roughly 77.61 (percent) of Guardion Health outstanding shares are held by general public with 1.3 % owned by insiders and only 21.09 pct. by outside corporations.Guardion Health Profitability Analysis
The company reported the previous year's revenue of 12.25 M. Net Income was 158.03 K with profit before overhead, payroll, taxes, and interest of 4.52 M.Guardion Health Past Distributions to stockholders
About Guardion Health Valuation
An absolute valuation paradigm, as applied to Guardion Pink Sheet, attempts to find the value of Guardion Health Sciences based on its fundamental and basic technical indicators. By analyzing Guardion Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Guardion Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardion Health. We calculate exposure to Guardion Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guardion Health's related companies.Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. Guardion Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.
8 Steps to conduct Guardion Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Guardion Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Guardion Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Guardion Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Guardion Health's revenue streams: Identify Guardion Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Guardion Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Guardion Health's growth potential: Evaluate Guardion Health's management, business model, and growth potential.
- Determine Guardion Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Guardion Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Guardion Health represents a small ownership stake in the entity. As a stockholder of Guardion, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Guardion Health Dividends Analysis For Valuation
Please note that Guardion Health has scaled down on payment of dividends at this time.
There are various types of dividends Guardion Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Guardion shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Guardion Health Sciences directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Guardion pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Guardion Health by the value of the dividends paid out.
Guardion Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.3 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |